The first NOAC with
a reversal agent
a reversal agent
YOUR FORESIGHT.
HIS FUTURE.
Pradaxa® (Dabigatran etexilate) is proven to effectively lower the risks of stroke, and gives you the assurance of reversibility with Praxbind® (Idarucizumab) in emergency situations.
Patient materials
MPR-PH-100057
Production date: July 2021
Production date: July 2021